Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
04/2010
04/13/2010US7695923 CFTR polypeptides methods to overcome biosynthetic misprocessing
04/13/2010US7695917 Rescue of gonadotropin releasing hormone receptor mutants
04/13/2010US7695903 diagnosing Alzheimer's disease by measuring abundance of low-density lipoprotein receptor related protein-1 (LRP-1), abundance of transcripts thereof, or LRP-1 receptor activity and comparing with an age-matched control
04/13/2010US7695902 Contacting test solution containing Rna and enzyme; hybridization
04/13/2010US7695732 Nutritional composition for the treatment of pressure ulcers
04/13/2010US7695729 Nonoral preparation having three-layer structure
04/13/2010US7695723 Methods of treating neurological conditions with hematopoietic growth factors
04/13/2010US7695722 Methods for reducing GNRH-positive tumor cell replication
04/13/2010US7695721 Gonadotrophins in the treatment anovulatory women
04/13/2010US7695720 target VEGFR2 (KDR/flk-1); for treating and preventing tumors
04/13/2010US7695718 Methods for the treatment of IL-1β related diseases
04/13/2010US7695715 Monoclonal antibodies, antigens and diagnosis and therapy of malignant diseases
04/13/2010US7695714 Use of alkaline phosphatase to maintain healthy tissue mass in mammals
04/13/2010US7695711 Δ 4,5 glycuronidase nucleic acid compositions
04/13/2010US7695710 a protein analog of a native human interferon-alpha covalently attached to at least one hydrophilic linear or branched polyethylene glycol polymeric chain; for treating hepatitis infections; side effect reduction
04/13/2010CA2472280C Cytotoxic cyplasin of the sea hare, aplysia punctata, cdna cloning and expression of bioreactive recombinants
04/13/2010CA2449747C Use of fkbp chaperones as expression tool
04/13/2010CA2435301C Multi-arm block copolymers as drug delivery vehicles
04/13/2010CA2431308C Regulation of angiogenesis with zinc finger proteins
04/13/2010CA2407683C Topical anesthetic/opioid formulations and uses thereof
04/13/2010CA2386863C Antigenic modification of polypeptides
04/13/2010CA2374997C Il6ril6 chimera for the treatment of neurodegenerative diseases
04/13/2010CA2372468C Compounds exhibiting an antibiotic activity
04/13/2010CA2363639C Covalently bridged insulin dimers
04/13/2010CA2348773C Functional antagonists of hedgehog activity
04/13/2010CA2330206C Poly(adp-ribose) polymerase gene
04/13/2010CA2321268C Liquid crystal forms of cyclosporin
04/13/2010CA2318482C Il-18 receptors
04/13/2010CA2314397C Novel peptide, apoep1.b, compositions and uses thereof
04/13/2010CA2265500C Novel semaphorin gene: semaphorin y
04/13/2010CA2263675C Compositions comprising an inducing agent and an anti-viral agent for the treatment of blood, viral and cellular disorders
04/13/2010CA2257357C Humanized antibodies with modified glycosylation
04/13/2010CA2232264C Variants of human recombinant interferon-.gamma. (rhu-ifn-.gamma.) with increased thermal stability
04/13/2010CA2224003C Fluorescence resonance energy transfer screening assay for the identification of hiv-1 envelope glycoprotein-medicated cell
04/13/2010CA2203528C Methods and kits using macrophage stimulating protein
04/13/2010CA2200868C Cdr-grafted type iii anti-cea humanized mouse monoclonal antibodies
04/13/2010CA2189015C Methods and compositions for the treatment of glomerulonephritis and other inflammatory diseases
04/13/2010CA2153593C Compositions and methods for delivery of genetic material
04/13/2010CA2089229C Cd40cr receptor and ligands therefor
04/08/2010WO2010040147A2 Site-specific n-terminal modifications of proteins and conjugate formation
04/08/2010WO2010040096A2 Methods for the treatment of graft-versus-host disease
04/08/2010WO2010040054A2 Methods for suppressing toll-like receptor activity
04/08/2010WO2010040051A2 Membrane resident peptide in anti-cancer peptides causes tumor cell necrosis rather than apoptosis of cancer cells
04/08/2010WO2010040029A1 Methods of modulating the negative chemotaxis of immune cells
04/08/2010WO2010040001A1 New hcv entry factor, occludin
04/08/2010WO2010040000A2 A multicomponent vaccine for malaria providing long-lasting immune responses against plasmodia
04/08/2010WO2010039985A1 Therapeutic Ribonucleases
04/08/2010WO2010039890A1 Benign solvents for forming protein structures
04/08/2010WO2010039872A1 Pulse parathyroid hormone for treatment of the hematopoietic syndrome, stromal cell loss, and vascular injury resulting from acute exposure to lethal radiation
04/08/2010WO2010039717A1 Implantable device for the delivery of octreotide and methods of use thereof
04/08/2010WO2010039690A1 Method of inhibiting biomaterial-induced procoagulant activity using complement inhibitors
04/08/2010WO2010039643A1 Implantable device for the delivery of histrelin and methods of use thereof
04/08/2010WO2010039563A2 Protective vaccine against staphylococcus aureus biofilms comprising cell wall-associated immunogens
04/08/2010WO2010039533A2 Methods for predicting production of activating signals by cross-linked binding proteins
04/08/2010WO2010039510A2 Use of syndyphalin-33 (sd-33; try-dmet(o)-gly-methylphenylethylamide) as a therapeutic agent to enhance the health and well-being of newly-weaned animals
04/08/2010WO2010039461A2 Methods for synthesis and uses of inhibitors of ghrelin o-acyltransferase as potential therapeutic agents for obesity and diabetes
04/08/2010WO2010039088A1 Chemically modified cell-penetrating peptides for improved delivery of gene modulating compounds
04/08/2010WO2010039048A1 Compositions and methods for treatment of radiation exposure
04/08/2010WO2010038796A1 Therapeutic agent for hepatitis c
04/08/2010WO2010038756A1 PHARMACEUTICAL COMPOSITION FOR TREATING BONE DISEASES WHICH COMPRISES PROTEIN COMPRISING Frizzled1, Frizzled2 OR Frizzled7 EXTRACELLULAR CYSTEINE-RICH DOMAIN
04/08/2010WO2010038610A1 Novel cartilage cell proliferation and differentiation inducer
04/08/2010WO2010038220A1 Peptide sequences, their branched form and use thereof for antimicrobial applications
04/08/2010WO2010038040A1 Treatment of biofilms
04/08/2010WO2010037930A1 Novel octapeptide compounds derived from somatostatin and therapeutic use thereof
04/08/2010WO2010037841A1 Treatment of mood and anxiety disorders
04/08/2010WO2010037695A1 Enzyme composition and application thereof in the treatment of pancreatic insufficiency
04/08/2010WO2010037514A2 Novel immunotherapy against several tumors including neuronal and brain tumors
04/08/2010WO2010037513A1 Composition of tumor-associated peptides and related anti-cancer vaccine for the treatment of glioblastoma (gbm) and other cancers
04/08/2010WO2010037402A1 Molecular vaccines for infectious disease
04/08/2010WO2010037397A1 Mhc multimers in cmv immune monitoring
04/08/2010WO2010037352A1 Pharmaceutical composition utilising combinations of variants of the gonadotropin-liberating hormone (gnrh) as immunogen
04/08/2010WO2010037351A1 Peptide antagonist of interleukin-15 activity
04/08/2010WO2010037284A1 Polypeptides for treating or preventing cancers, the derivative products and uses thereof
04/08/2010WO2010037224A1 Method for preventing and treating cardiovascular diseases with brca1
04/08/2010WO2010037208A1 Production of products of pharmaceutical interest in plant cell cultures
04/08/2010WO2010037173A1 Bile acids and biguanides as protease inhibitors for preserving the integrity of peptides in the gut
04/08/2010WO2010037152A1 Use of afamin for treating fertility disorders
04/08/2010WO2010016935A3 Truncated analogues of glucose-dependent insulinotropic polypeptide
04/08/2010WO2010011347A9 Clip inhibitors and methods of modulating immune function
04/08/2010WO2010009380A9 Methods for treating immune-mediated dengue fever infections and antibody-dependent enhancement of dengue fever infections, including dengue hemorrhagic fever and dengue shock syndrome
04/08/2010WO2009158025A3 Methods for dosing an actriib antagonist and monitoring of treated patients
04/08/2010WO2009155556A3 Crkl targeting peptides
04/08/2010WO2009155504A9 Methods for the modulation of angiogenesis
04/08/2010WO2009149675A3 Pseudacyclin and method of indication of a fungus pseudallescheria boydii
04/08/2010WO2009149379A3 Use of leptin for the treatment of fatty liver diseases and conditions
04/08/2010WO2009149161A9 Chimeric natriuretic polypeptides and methods for inhibiting cardiac remodeling
04/08/2010WO2009149148A9 Long-acting glp-1 derivatives, and methods of treating cardiac dysfunction
04/08/2010WO2009137829A3 Directed stem cell recruitment
04/08/2010WO2009135019A3 Methods and compositions for prostate cancer immunotherapy
04/08/2010WO2009075854A3 Effective quantitation of complex peptide mixtures in tissue samples and improved therapeutic methods
04/08/2010WO2009072005A3 Cxcl12 gamma a chemokine and uses thereof
04/08/2010WO2008155509A9 Modified human factor vii/viia and pharmaceutical composition containing same
04/08/2010US20100087851 Methods and Compositions for Sealing and Adhering Biological Tissues and Medical Uses Thereof
04/08/2010US20100087632 VEGF-Binding Fusion Proteins and Therapeutic Uses Thereof
04/08/2010US20100087624 Methods for making recombinant proteins using apoptosis inhibitors
04/08/2010US20100087621 Immune reactivity to her-2/neu protein for diagnosis and treatment of malignancies in which the her-2/neu oncogene is associated
04/08/2010US20100087514 Method and means for treatment of osteoarthritis
04/08/2010US20100087513 Microrna molecules
04/08/2010US20100087512 Microrna molecules
04/08/2010US20100087510 Novel Adaptor protein that binds to mammalian toll-like receptor 3 and gene thereof
1 ... 651 652 653 654 655 656 657 658 659 660 661 662 663 664 665 666 667 668 669 670 671 ... 3163